Physician profile
Mini Willphine
NPI 1235538950
$2,435.85
in general payments reported to CMS, 2019-2025
7 companies · $2,116 in 2025
The $2,116 reported for 2025 was more than what 97% of Critical Care Medicine (Nurse Practitioner) providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $263 · 2023: $16.76 · 2024: $39.67 · 2025: $2,116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,349 · Food and Beverage: $823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,349.20 |
| Food and Beverage | $823.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,945.08 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atriclip Laa Exclusion System |
| Medtronic, INC. | $181.26 | 2022 | |
| Abiomed | $175.38 | 2022-2025 | |
| La Jolla Pharmaceutical Company | $55.15 | 2024-2025 | Giapreza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.08 | 2022 | |
| Haemonetics Corporation | $17.14 | 2025 | Teg6s Hemostasis System |
| Angiodynamics, INC. | $16.76 | 2023 | Angiovac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mini Willphine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.